Keyphrases
Absolute Benefit
7%
Adenocarcinoma
53%
All Cancer
7%
Aspirin
100%
Cancer Hazard
30%
Cancer Inpatients
7%
Cancer Metastasis
100%
Cancer Mortality
7%
Cancer Risk
100%
Clinical Characteristics
7%
Clinical Follow-up
7%
Distant Metastasis
30%
Early Reduction
7%
Electronic Records
7%
Hazard Ratio
76%
High Dose
7%
In Cancer
7%
Incident Cancer
100%
Initial Diagnosis
7%
Localized Disease
7%
Metastasis
30%
Metastasis Risk
15%
Odds Ratio
7%
Overall Risk
7%
Paper Records
7%
Patients with Colorectal Cancer
7%
Pharmacological Intervention
7%
Platelets
7%
Randomized Controlled Trial
100%
Randomized Trial
7%
Risk Reduction
15%
Slow-release Formulations
7%
Smokers
7%
Solid Cancer
15%
Systemic Bioavailability
7%
Trial Participants
7%
Trial Population
7%
Tumor Histology
7%
Vascular Events
7%
Working Diagnosis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Adenocarcinoma
53%
Bioavailability
7%
Cancer Mortality
7%
Colorectal Carcinoma
7%
Diseases
7%
Distant Metastasis
30%
Malignant Neoplasm
38%
Neoplasm
7%
Randomized Controlled Trial
100%